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William James Blakely 
CHARACTERIZATION OF A PUTATIVE ACID PHOSPHATASE IN 
TOXOPLASMA GONDII AND ITS ROLE IN PARASITE PROPAGATION 
The parasite Toxoplasma gondii infects approximately one-third of people 
worldwide. Infection can lead to severe disease in those with a compromised 
immune system and primary infection during pregnancy can lead to severe birth 
defects or miscarriage. Treatment options are limited, have significant side 
effects, and are ineffective for all infection stages. Imperative to the discovery of 
novel therapeutic targets is a thorough understanding of how Toxoplasma 
propagates within a host. To replicate, the parasite must enter the cells of an 
infected organism where, during the invasion process, it surrounds itself with host 
cell membrane to form a parasitophorous vacuole (PV), within which it freely 
divides. To endure the intracellular environment of a host cell, Toxoplasma 
secretes a large repertoire of proteins beyond the PV to manipulate important 
host cellular functions. How these Toxoplasma proteins transit from parasites to 
host cell is not well understood. Protein translocation into the host cell is 
mediated by three proteins hypothesized to function as a putative translocon 
complex inside the PV, but whether other proteins are involved in the structure or 
regulation of this putative translocon remains unknown. The secreted protein 
GRA44, which contains a putative acid phosphatase domain, has been 
discovered to interact with members of this translocon and is required for 
downstream alteration of host cells. GRA44 was found to be post-translationally 




of the secretory pathway with both major cleavage products secreted to the PV. 
Conditional knockdown of GRA44 resulted in loss of host cell cMyc upregulation, 
a phenotype also seen in translocon member disruption. Therefore, the putative 
acid phosphatase GRA44, in association with the translocon complex, is critical 
for host cell manipulation during infection, a process Toxoplasma relies upon for 
successful propagation as an intracellular pathogen. 
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Chapter 1: Introduction 
Background 
Toxoplasma gondii was first discovered in1908 at the Pasteur Institute in 
Tunis by Nicolle and Manceaux, who were studying leishmaniasis in a small 
rodent species1.  Upon realization they had discovered a new organism, Nicolle 
and Manceaux named it Toxoplasma gondii, referencing the Greek word toxos, 
for bow or crescent based on the shape of the parasite, and gondii for the rodent 
they purportedly studied, Ctenodactylus gundi.  Toxoplasma was also discovered 
by Splendore the same year in Brazil, but it was not assigned a name, due to 
initial misidentification as Leishmania. 
Toxoplasma is a member of the phylum Apicomplexa, which includes 
other unicellular parasitic species like Plasmodium spp., Cryptosporidium spp., 
Cyclospora spp. and Babesia spp., all of which contain particular apically 
localized organelles distinct from other eukaryotes. These organisms exhibit 
complex life cycles with many stages of development and infect a wide variety of 
hosts and vectors worldwide2. In general, Toxoplasma exists in two distinct 
replicative stages: sexual and asexual. Sexual reproductive stages are restricted 
to felines, making them definitive hosts, while asexual replication can occur in all 
warm-blooded animals. Animals that can only harbor the asexual stages are 
considered intermediate hosts. 
The life stages of sexual reproduction only occur in the feline gut 
microenvironment. In the feline gut, parasites invade endothelial cells and form 




for sexual reproduction.  Fertilization of a macrogamete by a microgamete results 
in oocyst formation.  Oocysts travel through the feline gut and are shed to the 
outer environment where they remain viable and infectious to other felines and 
intermediate hosts. 
The life stages of asexual parasites occur in both definitive and 
intermediate hosts. Asexual parasites are termed either tachyzoites, tachy from 
the Greek word for "fast", or bradyzoites, from the Greek for "slow". Tachyzoites 
are a hyper replicative stage directly responsible for host cell and tissue damage 
resulting from parasite replication3. Tachyzoites are thus responsible for acute 
toxoplasmosis but they are typically susceptible to the immune response. In 
immunocompetent hosts, tachyzoites convert to the encysted bradyzoite stage 
as a means to evade the immune response. As bradyzoites, parasites form 
protective tissue cysts within infected cells and avoid clearance. Accordingly, 
bradyzoites can remain for the entirety of a host's lifespan establishing a chronic 
infection.  Toxoplasma is capable of infecting most tissues, but some tissues 
appear to be more commonly infected.  Specifically, tissue such as muscle/heart 
and nerve/brain are disproportionately infected and often harbor bradyzoite cysts. 
These latent tissue cysts are capable of reactivation upon reduced immune 
pressure, with bradyzoites becoming tachyzoites to resume rapid replication. 
Both oocysts and bradyzoite tissue cysts can be infective and 
consumption of either results in parasites being released by digestive enzymes 
and invading proximal tissues4.  Parasite oocysts shed in cat feces can be found 




vegetables and direct ingestion of these cysts can result in transmission to other 
hosts including humans. Similarly, ingestion of tissue cysts in undercooked or 
raw meat from infected animals can transmit parasites to a new host. Infection 
from undercooked, cured, or raw meat is most common from wild game or free-
range livestock, since these animals have increased contact with the 
environment and feline species4,5. Swine such as commercial hogs or feral pigs 
have been found to have the highest rates of Toxoplasma infection, with poultry 
such as chickens to be second in seropositivity rates. In summary, Toxoplasma 
has been found capable of infecting almost any nucleated cell of all warm-
blooded organisms including mammals and birds and has various modes of 
transmission including food borne. A wide variety of potential hosts, coupled with 
an aptitude for long term viable dormancy, has allowed for a breadth of infection 
not seen in most pathogens. 
Health impacts of toxoplasmosis 
In humans, Toxoplasma is limited to asexual parasite stages and 
infections are classified as either acute or chronic. An acute infection is 
characterized by the highly-proliferative tachyzoite parasite form, which is 
responsible for host cell lysis and ultimately tissue damage and lesions of the 
infected area if left unchecked by the immune system6.  Conversely, a chronic 
infection is characterized by predominance of the bradyzoite parasite form, which 
undergoes limited replication and produces latent parasite cysts throughout host 
tissues. Bradyzoites remain mostly dormant, but persist for the duration of the 




Globally, Toxoplasma infection is estimated to occur in one-third of the 
human population, with certain regions of Europe, South America and Southeast 
Asia having highest infection rates ≥ 60%. In the United States, an estimated 
15% of the population is positive for infection4,8. Infections typically begin as 
acute, but are quickly suppressed by host immune pressures, resulting in a 
mostly asymptomatic chronic infection. Chronic infections can re-activate, 
however, and become acute upon weakened host immunity. Left unchecked, an 
acute infection results in severe tissue damage. Toxoplasmic encephalitis and 
other pathological complications are a significant risk to immunocompromised or 
immunosuppressed individuals such as organ transplant recipients, HIV/AIDS 
patients and lymphoma patients7,9,10. Toxoplasmic encephalitis has been 
observed in 30-50% of HIV positive patients with up to 80% of AIDS patients 
having evident brain lesions as detected by MRI. Of those affected by 
Toxoplasmosis who are HIV negative, approximately 40% are patients 
undergoing treatment or in remission from lymphomas. Further, toxoplasmosis 
can develop congenitally from primary infections in pregnant women, where 
parasites are passed from the mother to the developing fetus, causing severe 
birth defects or miscarriage11. Although less than 1% of pregnancies are affected 
by Toxoplasma infection, 85% of congenitally infected infants with presumed 
normal physiology yielded signs of mental retardation and vision loss later in 
development. While rare, postnatal ocular toxoplasmosis is an infection which 




Upon infecting a host, parasites typically invade nearby cells and begin to 
replicate.  Infection can spread within the infected organism by parasite invasion 
of host macrophages, which travel to distant tissues and release tachyzoites in 
new areas. Increasing numbers of free and intracellular tachyzoites can elicit a 
host immune response. Immune system activation results in typical feverish 
symptoms mirroring a common influenza infection and is often similar in duration. 
A healthy immune response can thwart tachyzoite replication and push the 
parasites into the bradyzoite stage. As bradyzoites, Toxoplasma forms protective 
cysts inside host cells and remains undetectable by the immune system. While 
encysted parasites have been thought to be mostly dormant, new evidence 
suggests that they are physiologically active, can divide, and elicit an 
inflammatory reaction. Whether the encysted stage is associated with disease, 
including those with inflammatory etiology, has become a focus of significant 
investigation. 
Currently, the recommended treatment for a Toxoplasma infection is a 
combination therapy of pyrimethamine and sulfadiazine13. Pyrimethamine 
counteracts parasite replication by preferentially inhibiting parasite dihydrofolate 
reductase, a common enzyme important for nucleic acid synthesis, and 
sulfadiazine disrupts folic acid synthesis by inhibiting the enzyme dihydropteroate 
synthetase. Toxoplasma is unable to obtain folate from its host and therefore 
must synthesize it de novo, making the parasites susceptible to folate synthesis 
inhibition. This regimen has undesirable side effects, however, and is only 




alternative treatment which targets the parasites' mitochondria; however 
increasing drug resistance has reduced its usefulness15 and there are no 
approved treatments for a chronic Toxoplasma infection. 
Toxoplasma gondii cell biology 
Toxoplasma is of eukaryotic origin and exists as a crescent-shaped cell 
during asexual stages16. The parasite has no outer cell wall or protective glycan 
structure, but just a singular plasma membrane bilayer. Underneath the plasma 
membrane is a double-membrane complex originating from a series of large 
flattened vesicles stitched together and termed the inner membrane complex 
(IMC). Supporting the membrane structures is a complex cytoskeleton largely 
comprised of microtubules (Figure 1). The apical end of the cell is supported by a 
conoid complex which contains a set of two apical rings derived from 
membraneous structure connected atop a large cone-shaped polar ring 
consisting of 6-8 microtubules wound in a corkscrew configuration. Another ring 
connects the bottom of this polar ring and supports a set of longitudinal 
microtubules.  There are 22 longitudinal microtubules in total, arranged in a spiral 
pattern, which cover the majority of the cell. In addition, two internal parallel 






Figure 1. Apical complex of Toxoplasma 
Two internal microtubules span the entire length of the parasite(a). 
The conoid complex consists of apical ring 1 (b), apical ring 2 (c), 
conoid (d), polar ring 1 (e) and polar ring 2 (f). IMC (g) starts at 
polar ring 1. Longitudinal microtubules (h) provide outer mechanical 
support for most of cell length. 
 
When intracellular, parasites reside within a single shared protective 
vacuole structure, known as the parasitophorous vacuole (PV), which grows in 
size as the parasites replicate. The PV consists of a single outer membrane, the 
PV membrane (PVM), and an inner lumen space. The PVM is a nonfusogenic 
lipid bilayer derived from host cell membrane and contains many embedded 
parasite proteins17. Within the PV lumen are individual parasites and a complex 
network of actin filaments and vesicles, termed the tubulovesicular network 
(TVN). In order to obtain necessary nutrients from the host cell, parasites secrete 
a variety of factors to the PV. The PV contains passive pore structures that allow 
passage of organic molecules and small peptides up to a size of 1.3 to 1.9 
kDa18,19. PV membrane transporters and members of the PV pore structures, 




parasites are vulnerable to host immunity while extracellular due to a lack of 
innate defense mechanisms and thus tend to quickly invade nearby host cells, 
constructing a PV on invasion. The PV acts as a barrier to host cell cytoplasm 
and safeguards against host endolysosomal degradation. If parasites suffer from 
environmental stressors while in the PV, the PVM is modified with additional 
proteins and heavy glycosylation to form the cyst wall, shielding parasites from 
an unsuitable environment. 
As a eukaryotic cell, Toxoplasma contains common subcellular organelles 
such as a nucleus, endoplasmic reticulum, Golgi body and a single 
mitochondrion16. Although the parasite has organelles typical of eukaryotes, 
Toxoplasma is auxotrophic for certain nutrients, such as purines, sterols and 
select amino acids, and must invade a host for continued survival2. This nutrient 
dependency is complemented by a parasitic lifestyle, leading to considerable 
evolutionary divergence from other phyla20. Since Toxoplasma relies on a host 
for survival, they have several parasite-specific organelles to support their 
biological niche. The micronemes, rhoptries and dense granules are dedicated 
organelles of the secretory pathway that coordinate induction of necessary 
parasite secretions to affect the host and expedite parasite propagation. 
Micronemes and rhoptries are located at the apical end of the parasite, while 
dense granules are distributed throughout the cell. The apicoplast is another 
specialized organelle of obscure function. This organelle contains its own DNA 
and is likely derived from an ancient algae cell, which is presumed to have been 




established an initial symbiotic relationship and there are relatives of Toxoplasma 
that exhibit photosynthetic abilities supported by an apicoplast. It is evident, 
however, that Toxoplasma itself has lost this photosynthetic trait as it became 
increasingly adapted to a parasitic life cycle. Instead, the apicoplast of 
Toxoplasma is responsible for de novo synthesis of various lipids such as 
isoprenoids, short-chain fatty acids and heme precursors, thereby remaining an 
essential organelle. Interestingly, significant exchange of genetic material has 
likely occurred between the apicoplast and parasite nucleus, giving rise to a 
mixed genome of both plant-like and mammalian genes that is collectively shared 
across the two organelles. Lastly, Toxoplasma has a small vacuolar structure 
called the plant-like vacuole (PLV), which associates with another substructure 
termed the vacuolar compartment (VAC)21,22. These structures are not well 
studied, but it has been hypothesized they are part of an endo-lysosomal system 
and may coordinate to play a role in ion homeostasis or protein processing due 
to presence of specifically localized ion channels and to a lower pH within the 
PLC analogous  to endosomes. 
Asexual replication gives rise to a cyclical propagation pattern. The first 
step is extracellular attachment of the parasite to a host cell plasma membrane, 
followed by indentation of the host membrane at the attachment site and 
formation of a structure termed the moving junction6,23. The moving junction 
facilitates subsequent invasion of the parasite into the host intracellular space.  
As a parasite invades, it pulls the host plasma membrane with it to become 




pinches off the membrane at the moving junction to form the PV, expelling any 
remnant host proteins. Once in the PV, parasites replicate asexually through 
endodyogeny. Endodyogeny is a specific mechanism of cellular division, where 
two daughter cells are formed within a mother cell and the mother organelles are 
split between the two forming daughters. As parasites replicate, the PV grows, 
until a critical point at which the host cell is unsustainable. At this point, the 
parasites quickly release high levels of intracellular calcium, triggering a 
controlled egress cascade of the host cell where the PV is deconstructed, host 
cell membrane is permeabilized and parasites become motile, leaving the host 
cell remnants behind. Shortly after egress, parasites attach and reinvade 
neighboring host cells to repeat the cycle. This cycle of attachment, invasion, PV 
formation, replication and egress can repeat indefinitely, barring interruptive host 
or environmental factors and has been termed the parasite lytic cycle.  
Unchecked progression of the lytic cycle results in host cell lysis and tissue 
damage on a macroscale. 
Interactions with the host cell 
During the lytic cycle, parasites secrete a wide range of factors to 
accomplish the steps driving the cycle's progression (Figure 2)23. Extracellular 
parasites secrete attachment factors from the micronemes, which are important 
for driving motility and attachment to host cells. Upon attachment, the rhoptries 
begin to secrete factors as micronemal secretions lessen. Proteins secreted from 
a subcompartment of the rhoptries, known as the rhoptry neck, are first secreted 




establish the moving junction structure. During and after invasion, proteins from 
the rhoptry bulbs are secreted. Formation of the PV is accompanied by 
diminished rhoptry secretion and the start of secretion from the dense granules. 
Dense granule proteins are continuously secreted to set up and maintain 
structures within the PV, such as the intravacuolar network. 
 
Figure 2. Lytic cycle and protein secretion. 
Attachment is mediated by secretion of micronemal proteins (MICs). 
Rhoptry neck proteins (RONs) are secreted to facilitate invasion, 
followed by secretion of other rhoptry proteins (ROPs). Dense 
granule proteins (GRAs) are secreted after establishment of the PV. 
 
To facilitate propagation and survival as an intracellular pathogen, 
Toxoplasma depends upon interaction with the host cell. While in the PV, 
parasites are safely inaccessible to host degradation pathways, however they are 
also restricted in their access to host cell structures and systems. To amend this 
isolated situation, Toxoplasma interfaces with host cell processes by secreting an 
arsenal of protein factors beyond the PV into the host, effectively sabotaging host 
systems for parasite benefit2. Dense granule proteins and some late rhoptry 
proteins are secreted from the mature PV and play major roles in parasite 
secretions to the host and host systems manipulation. Many protein factors 
secreted beyond the PV manipulate host pathways such as transcription, 




known to be critical for host manipulation are ROP16 and ROP1824,25. The kinase 
ROP16 affects host transcriptional signaling to cause downregulation of STAT3/6 
in the host nucleus. This effectively alters host transcription of major gene sets. 
The kinase ROP18, in coordination with the disordered dense granule protein 
GRA7, neutralizes innate host cell immune mechanisms by phosphorylation and 
inactivation of host Immunity-Related GTPase (IRG) proteins26. The 
pseudokinase ROP5 has also been implicated as a cofactor in this neutralization 
process. Host IRG proteins naturally bind foreign structures, such as the 
parasite-derived PV, and signal for trafficking to the host endosomal degradation 
pathway. Recently, the parasite kinases WNG1 and WNG2, have been shown to 
be important for maintenance of parasite PV membrane integrity27,28. 
Additionally, the dense granule protein GRA16 has shown to be an activator of 
host cMyc and disregulates p53 upon parasite infection29. Amplified cMyc 
expression can cause increased host cell proliferation and metabolism and 
altered p53 pathways affect the host's cell cycle. 
The mechanisms by which parasite proteins are secreted out into the PV 
lumen and beyond to the host cytosol and nucleus are largely unknown. To begin 
understanding this phenomenon, randomly mutagenized parasite populations 
were screened for loss of protein secretion to host cells30. Parasites with 
deficiencies in secretion were identified by their failure to induce host nuclear 
cMyc in the respective infected host cell. Parasites failing to upregulate host 
cMyc were isolated and characterized by genome sequencing. Three genes were 




defect31. The three gene products localize to the PV and were named MYR1/2/3 
(Myc Regulation1/2/3). Furthermore, these proteins were shown to be directly 
responsible for translocation of other proteins such as GRA16 and GRA24 
beyond the PV to the host and are thus indirectly responsible for manipulation of 
a wide range of host systems32. It can then be surmised that in addition to 
proteins secreted to the host and PV membrane, some specific proteins are 
secreted to the PV lumen for the purpose of trafficking host-bound factors. 
The secretion pathway is understood to contain a Golgi-localized 
protease, aspartyl protease V (ASP5)27,33,34. This protease cleaves a majority of 
secreted proteins at a consensus motif RRL. The ASP5 recognition site present 
exclusively in secreted proteins has been termed TEXEL (Toxoplasma Export 
Element). Studies of ASP5 have shown that its deletion results in uncleaved 
secreted proteins, but these proteins are nevertheless still secreted. Therefore, 
the ASP5 enzyme is evidently not highly essential for effector secretion to host 
cells, in contrast to the MYR1/2/3 proteins. Knockout of ASP5 results in only a 
partial subset of the host transcriptomic changes as seen for MYR1 knockouts32. 
Site-specific cleavage of secreted proteins is also seen in the related parasite, 
Plasmodium spp., which has an ER-localized protease Plasmepsin V35.  
Plasmepsin V was documented prior to ASP5 and both proteases share a high 
degree of identity. The consensus motif of Plasmepsin V in Plasmodium is similar 
to Toxoplasma and is termed PEXEL (Plasmodium Export Element) that has a 





In biology, phosphatases have a broad set of roles that center on their 
primary function of cleaving phosphate groups from substrates. Many 
phosphatases act on signaling pathways in opposition to kinases and cells use 
this binary relationship to balance or regulate cellular processes37–39. 
Phosphatases that act exclusively on other proteins as a means of regulation are 
denoted PP for protein phosphatase40. Phosphatases of this type typically consist 
of a single catalytic phosphatase domain with many binding sites to multiple 
binding partner domains. When coupled to the phosphatase domain, partner 
domains confer substrate specificity and binding ability. This process is 
analogous in concept to the E2-E3 ligase relationship of the ubiquitination 
pathway. Protein phosphatases are separated into two types: serine/threonine 
and tyrosine phosphatases. These two types are only capable of 
dephosphorylating either phosphoserine/threonine or phosphotyrosine residues 
in their substrates. They can be further classified by protein structure, where 
phosphatases utilizing a metal structural center are termed PPM phosphatases41. 
Phosphatases do not only act on proteins, however, and many have roles 
in metabolism where they facilitate necessary chemical reactions of nutrient 
consumption or organic molecule alteration for trafficking and storage42. A distinct 
class of phosphatases are the metallophosphatases or acid phosphatases. 
These enzymes have many biological functions and diverse roles43.  Unlike other 
phosphatase families, these enzymes are classified by their unusual catalytic 




a shared similar metal-dependent active site. In the active site, two metals are 
coordinated in such a way as to hydrolyze a stabilized phosphate group from the 
substrate44. Contrary to other metal-binding phosphatases, metallophosphatases 
do not use the metals for structure, but rather for catalysis. Since they utilize 
metal atoms, this phosphatase type is frequently pH dependent and those active 
at lower pH are called purple acid phosphatases due to their iron-derived purple 
hue when in acidic conditions. Metallophosphatases often coordinate an Fe(III) 
and a second divalent metal atom. Mn(II), Zn(II) or Fe(II) are common secondary 
metals. Esterolysis of a phosphate group from a substrate occurs through 
multiple steps beginning with a precatalytic complex originating from two oxygens 
of the phosphate and the two metals of the active site44. A bridging hydroxyl, 
natively conjugated to the enzyme active site metals, initiates a nucleophilic 
attack on the complexed phosphate, expelling the substrate as a leaving group. 
Following substrate release and subsequent electron rearrangements, the bound 
phosphate is released by reaction with a water molecule to regenerate the native 
active site configuration containing a hydroxyl bridge. Acid phosphatases serve a 
wide variety of biological functions across most organisms and are especially 
common in plants42. In humans, these enzymes have documented roles in the 
downregulation of prostate cell growth through dephosphorylation of ErbB-2 in 
prostatic cancer and for facilitating osteoclast bone resorption activity by 
dephosphorylation of bone matrix proteins, such as osteopontin45,46.  In plants, 
acid phosphatases have roles in organic phosphate acquisition and pathogen 




phosphatase in tobacco cells has been found to regulate enzymatic activity of 
glycosidases found in the cell wall50. 
In Toxoplasma, acid phosphatases and metallophosphatases have not 
been studied extensively. The proteins GAP45 and GAP50, both of which have 
regions of homology to acid phosphatase domains, have been studied in greatest 
detail and are important elements of the glideosome complex, a large multi-
protein complex responsible for the parasite's gliding motility51. 
Basis of inquiry 
Secreted proteins are suggested to alter host signaling pathways through 
enzymatic activity, such as kinases and phosphatases, and hence are of great 
interest as potential drug targets. The uniqueness of the Toxoplasma proteome 
and importance of secreted effectors to parasite propagation make this class of 
proteins especially attractive for therapeutic intervention. Historically, secreted 
kinases have been the major focus of study among secreted proteins with 
potential for drug inhibition.52 In contrast, the contribution of secreted 
phosphatases remains largely unexplored. The secreted phosphatase PP2C-hn 
is the lone example, trafficking to the host cytoplasm and nucleus, but its function 
remains unclear53. To expand understanding of phosphatases secreted to either 
the host or PV, 32 genes were identified encoding proteins predicted to have a 
signal sequence and phosphatase domain. From these efforts, I identified 
TGGT1_228170 as a potential candidate for further study. Although previously 
identified in brief as part of the inner membrane complex and named IMC2A by 




protein, namely an N-terminal signal sequence and putative TEXEL sites54. 
Additionally, the Tg228170 gene of Toxoplasma has been predicted to be 
essential to parasite fitness as described by Sidik et al. in their work detailing a 
gene fitness scoring scheme across the entire Toxoplasma genome. In their 
study, each gene of Toxoplasma was functionally deleted and resultant changes 
to parasite fitness were scored on a scale relative to wild-type parasites. Overall, 
this collection of information paired with the knowledge that Toxoplasma utilizes 
a great degree of secretion-based host manipulation for a parasite advantage led 
me to hypothesize that the protein, once designated as IMC2A, is a secreted 
phosphatase important to host manipulation and by extension, parasite 
propagation. 
Aim 1: Determine role of protein processing on localization and function.
 To determine the localization of GRA44, I engineered a parasite strain in 
which the endogenous gene encodes an HA epitope tag at the 3' end. Western 
blot analysis of the epitope tagged parasites revealed the presence of at least 
two forms: full length and a 45 kDa protein, which is consistent with the presence 
of a TEXEL site midway through the protein sequence. Accordingly, a second 
parasite strain was established containing an internal MYC epitope in addition to 
the 3' HA epitope for determining localization of all cleavage products. The 
double tagged GRA44 showed three protein sizes by western blot corresponding 
to full-length protein, N-terminal, and C-terminal peptides.  Immunofluorescence 
assays using antibodies against both epitopes showed all protein forms are 




mutation of the consensus motif had no effects on GRA44 localization or 
function. 
Aim 2: Determine GRA44 importance 
 In order to understand the role of GRA44, I determined its function within 
the parasite through genetic disruption. As preliminary experiments suggested 
GRA44 is essential for parasite survival, a conditional knockdown approach was 
used for gene disruption. Phenotypic analysis of these knockdown parasites 
showed GRA44 to be essential for parasite growth and propagation. 
Aim 3: Identify GRA44 cellular role. 
 As a putative acid phosphatase, GRA44 has a large number of potential 
functions and substrates. Acid phosphatases can have roles in metabolism by 
dephosphorylation of various metabolic intermediates or cellular trafficking by 
dephosphorylation of certain vesicle phospholipid components.  Signaling is also 
a cellular process where acid phosphatases play a role by dephosphorylation of 
proteins relevant to signal cascades. Immunoprecipitation of GRA44 identified 
top interacting proteins, which included the protein MYR1 of the Toxoplasma 
translocation system. Intracellular Toxoplasma parasites typically induce 
changes to host cell biological programs and systems by translocating parasite-
derived effectors across the PV membrane via the translocon.  I found that 
GRA44 was necessary for translocon-mediated host cell alteration; specifically 
GRA44 knockdown parasites failed to activate host cell cMYC. Similarly, MYR1 




Chapter 2: Methods 
Cell culture 
Parasite cell lines were continuously propagated through host cells by 
regular passage into human foreskin fibroblasts (HFFs). HFF cells were 
purchased from ATCC. Parasites and HFFs were grown in Dulbecco’s modified 
Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 2 
mM/liter glutamine, 100 units penicillin/mL, and 100 μg streptomycin/ml. Dialyzed 
FBS was used during periods of pyrimethamine drug selection. All cell cultures, 
including parasites and separate HFFs, were grown in a humidified incubator at 
37°C with 5% CO2. Parasite lines originated from one of two parental RH strains: 
a strain lacking the hypoxanthine-guanine phosphoribosyltransferase (HPT) 
gene, referred to as RHΔhpt, and a strain lacking HPT and Ku80, referred to as 
RHΔku8056–58. Pyrimethamine and chloramphenicol stocks were prepared in 
ethanol and stocks of anhydrotetracycline (ATc) were prepared in dimethyl 
sulfoxide (DMSO). 
Parasite genetic manipulation and clonal selection 
Parasite populations were transfected with genetic constructs by a 
nucleofection system (Lonza) in provided P3 primary cell buffer and 1 mL 
cuvettes. To establish independent clonal lines, transfected parasite populations 
were subjected to limiting dilution followed by clone isolation. Parasite lines were 
confirmed by immunofluorescence microscopy and western blotting. Construction 
of DNA plasmid vectors was accomplished with the InFusion HD Cloning Plus 




vectors were linearized by restriction digestion and recombined with PCR-
amplified insert DNA. For mutant variations of TGGT1_228170, exogenous 
vector constructs were altered by site-directed mutagenesis, then transfected into 
parasites. TEXEL deletions, MYC epitope tag insertion, and TEXEL2 point 
mutations were accomplished using a Q5 site-directed mutagenesis kit (New 
England Biolabs), and TEXEL point mutations were similarly accomplished with a 
QuikChange site-directed mutagenesis kit (Agilent). 
For specific targeting of genetic elements to the Toxoplasma genome, a 
CRISPR/Cas9 based approach was used. To expedite the process, a specialized 
plasmid vector was adopted containing Cas9, driven by the native Toxoplasma 
promoter to Surface Antigen 1 (pSAG1), a guide RNA (sgRNA) driven by 
Toxoplasma U6 RNA promoter and appropriate drug selection cassettes for 
selective growth in both parasites and bacteria (pSAG1-Cas9-GFP-pU6-
sgUPRT)59. The original sgRNA is for the parasite uracil ribosyltransferase 
(UPRT) locus, but was replaced as needed for other genomic targets by site-
directed mutagenesis (Q5, New England Biolabs). Two sgRNAs were used, a 
guide sequence targeting upstream of the 228170 start codon for TATi promoter 
insertion and another sequence targeting the parasite Ku80 locus for gene 
complement construct insertion. Genetic constructs for insertion by CRISPR 
were amplified by PCR to contain 5' and 3' end homology regions to their 
respective Cas9 cut site. Following PCR amplification, insert DNA was purified by 





Epitope tagging strategy 
To endogenously tag TGGT1_228170 at the C-terminus, a 3'-region 
directly upstream of the stop codon was amplified by PCR from RHΔku80 
parasite genomic DNA and combined with pLIC-3xHA-DHFR vector previously 
linearized by PacI just upstream of the 3xHA epitopes58. Fifty micrograms of the 
resulting vector was linearized by XcmI and transfected into RHΔku80 parasites. 
The transfected population was selected for the presence of the pyrimethamine-
resistant dihydrofolate reductase (DHFR) allele of the parent vector60. To 
introduce an exogenous copy of TGGT1_228170 into parasites, a vector was 
generated to contain a section of the genomic TGGT1_228170 locus beginning 
from the start codon to the stop codon, including all intron segments and 
appended C-terminal HA epitope. The section of TGGT1_228170 in the vector 
was flanked by the Toxoplasma tubulin promoter with 5'-untranslated region 
(UTR) and the tubulin 3' UTR. This was achieved by cloning a PCR amplicon of 
the TGGT1_228170 genomic DNA into the vector pTNRluc-Tub-HPT at NcoI and 
PacI restriction sites61. Fifty micrograms of the resulting vector, pTub-Gra44-
HPT, was linearized with ScaI and transfected into RHΔhpt parasites. The 
transfected population was selected for HPT by maintained passage in media 
containing mycophenolic acid (50 μg/ml) and xanthine (50 μg/ml). Independent 
clones were isolated by limiting dilution.  
Conditional knockdown and complementation 
To generate the GRA44 conditional knockdown strain, a cassette 




Tetracycline response element (TRE) was introduced just upstream of the 
GRA44 start codon. The cassette was amplified from the vector pT8TATi-Gra44-
HX-tetO7S62. One microgram of this PCR amplicon was transfected into the 
RHΔku80 parasites already expressing endogenously HA-tagged GRA44. To 
drive insertion of the TATi cassette, the PCR amplicon was co-transfected with 2 
μg of Cas9 vector expressing a sgRNA targeting just upstream of the 
TGGT1_228170 start codon. Transfected parasites were selected for resistance 
to mycophenolic acid imparted by HPT, and independent clones established by 
limiting dilution. TATi cassette insertion was confirmed at the correct locus by 
PCR. The resulting strain was designatedTATi-GRA44(HA). To obtain a 
complementedTATi-GRA44(HA) line, a wild-type copy of TGGT1_228170 
including a C-terminal MYC epitope tag, driven by a Toxoplasma tubulin 
promoter, was targeted to the inactive ku80 locus of the TATi-GRA44(HA) strain 
by CRISPR/Cas9. The insertional cassette, which contains a tubulin-driven copy 
of TGGT1_228170 and chloramphenicol resistance gene, was amplified by PCR 
from plasmid pTub-Gra44-myc-CmR with primers to include homology segments 
to the ku80 locus63,64. The pTub-Gra44-myc-CmR vector was constructed by 
appending a C-terminal MYC tag to the GRA44 gene sequence, which was then 
amplified from pTub-Gra44-HP and inserted into the pLIC-SMGFP-CmR vector 
backbone. This engineering strategy effectively replaced the soluble green 
fluorescent protein (SMGFP) tagging region of the vector with GRA44(MYC), 




One microgram of PCR amplicon was co-transfected with 2 μg of the Cas9 
vector encoding the Ku80 sgRNA. 
Western blot analysis 
For qualitative protein detection by western blot, washed parasite samples 
were resuspended in 2x sample loading buffer with 5% β-mercaptoethanol and 
boiled for 5 min at 98°C. All boiled samples were frozen at -20°C, then thawed 
and reboiled for 5 min at 98°C prior to gel loading. SDS-PAGE and western 
blotting were performed by standard methods, as previously described65. For 
samples of extracellular parasite lysate, parasites underwent natural egress 
before being collected, then centrifuged, and washed two times with cold 
phosphate-buffered saline (PBS) (10 min, 1,000xg). For samples of intracellular 
parasite lysate, infected HFF monolayers, preceding natural egress, were 
washed 2 times with cold PBS, scraped, and centrifuged for 10 min at 1,000xg. 
To quantitatively analyze GRA44 conditional knockdown and 
complemented lines by western blot, parasites were first grown under normal 
conditions as described above for 24 hours, then syringe lysed with a 27-gauge 
needle. Fresh host cells were infected with an equal quantity of syringe-released 
parasites and grown for 24 or 48 hours in presence or absence of 1 μg/ml ATc. 
To analyze protein lysates from extracellular parasite samples of these lines, 
host cells were scraped and parasites released by passage through a syringe 
followed by centrifugation for 10 min at 1,000 x g. For analysis of intracellular 
parasite protein lysates, host cell monolayers were washed with cold PBS, 




resuspended in 200 μL immunoprecipitation assay lysis solution (50 mM Tris, 
150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1%Triton X-100) including 
a protease/phosphatase inhibitor cocktail (Cell Signaling Technology). Lysates 
were incubated on ice for 1 hour, sonicated 2 times for 15 seconds each that 
were spaced with 1 minute incubations on ice.  Samples were then clarified by 
centrifugation at 20,000 x g for 15 minutes at 4°C. Supernatants were combined 
with 4x SDS loading buffer with 10% β-mercaptoethanol (BME) and boiled for 5 
min at 98°C. The boiled SDS samples were frozen at -20°C, then thawed and 
reboiled for 5 minutes at 98°C before gel loading. SDS-PAGE and western 
blotting were performed as described above. The primary antibodies used for 
western blotting included rabbit anti-HA at a dilution of 1:1,000 (Cell Signaling 
Technologies, 3724), rabbit anti-MYC at a dilution of 1:1,000 (Cell Signaling 
Technologies, 2278), mouse anti-SAG1 at a dilution of 1:2,000 (Genway, 
GWB51EAB6), and mouse anti-MYR1 antibodies at 1:1,00030,31. The secondary 
antibodies used included peroxidase-conjugated goat anti-mouse and anti-rabbit 
immunoglobulins at a dilution of 1:10,000. 
Immunofluorescence assays 
For all immunofluorescence assays (IFA), HFFs were grown to confluence 
on 1.5-mm glass coverslips before infection with parasites. Infected coverslips 
were allowed to grow for 20 hours prior to 20 minute fixation in 4% 
paraformaldehyde. After fixation, cells were washed with PBS, then 
permeabilized and blocked with a solution of 3% bovine serum albumin (BSA), 




primary antibodies for 1 hour at room temperature in a solution of 3% BSA and 
0.2% Triton X-100 in PBS. These were then washed five times with PBS after 
primary antibody incubation. Finally, coverslip samples were incubated with 
fluorophore-conjugated secondary antibodies for 1 hour at room temperature in 
3% BSA in PBS, then washed five times with PBS and mounted on glass slides 
with Vectashield mounting medium containing DAPI (Vector Laboratories). 
Primary antibodies used were rabbit anti-HA at 1:1,000 (Cell Signaling 
Technologies, 3724), mouse anti-MYC at 1:1,000 (Cell Signaling Technologies, 
2276), rat anti-HA at 1:2,000 (Roche, 11867423001), rabbit anti-human cMyc at 
1:1,000 (Abcam, ab32072), mouse anti-gra5 (Biotem, BIO.018.6) at 1:1,000, and 
mouse anti-gra7 at 1:1,000. The secondary antibodies used (Life Technologies) 
were Alexa Fluor 488-conjugated goat anti-rabbit (A32731) or goat anti-rat 
immunoglobulin (A-11006), Alexa Fluor 594-conjugated goat anti-mouse (A-
11032) or goat anti-rabbit immunoglobulin (A-11012), and Alexa Fluor 647-
conjugated goat anti-mouse immunoglobulin (A-21235). All secondary antibodies 
were used at dilutions of 1:2,000. Images were taken on a Nikon Eclipse 80i 
microscope using a Nikon DS-Qi1Mc camera and NIS Elements AR (v3.0) 
software. 
Immunoprecipitation and proteomics 
Immunoprecipitation experiments with intracellular samples were 
accomplished by harvesting infected host cells prior to egress. HFF monolayers 
were washed 2 times with cold PBS and scraped from the flask surface to collect 




resuspended in 200 μL ice-cold IP lysis buffer (Pierce, Thermo Scientific) 
containing protease and phosphatase inhibitors (Cell Signaling Technology). 
Lysates were incubated on ice for 1 hour, sonicated on ice 2 times for 15 
seconds each time, then centrifuged for 15 min at 20,000xg and 4°C. 
Supernatants were collected and incubated with magnetic beads conjugated to 
either mouse immunoglobulin or primary antibody (Pierce, Thermo Scientific) for 
1 hour at 4°C with rocking. After incubation, beads were separated from solution 
by magnetism and washed with IP lysis buffer (Pierce, Thermo Scientific) 
containing inhibitors 3 times and either stored in 8 M urea at -80°C for 
downstream mass spectrometric analysis or directly eluted into 2x SDS sample 
loading buffer with 5% β-mercaptoethanol, boiled for 5 min at 98°C, and stored at 
-20°C for Western blot analysis. SDS-PAGE and western blotting were 
performed as outlined above. Samples for mass spectrometry were denatured 
and digested with trypsin before analysis by an Orbitrap Fusion Lumos mass 
spectrometer. Protein mass spectrometry analysis was completed by the Indiana 
University School of Medicine Proteomics Core facility. Results were processed 
by the SAINT (Significance Analysis of Interactome) computational program for 
statistical quantification and to define significant protein interactions66. A SAINT 
probability of 0.8 was used as a cutoff and interactors ranked by the most  
stringent fold change metric (Fold Change B). 
Parasite growth assays 
Twelve-well tissue culture plates of confluent HFFs were infected with 500 




undisturbed for 5 days before fixation with methanol for 5 min. Fixed wells were 
stained with crystal violet, and plaque images quantified with ImageJ software 
using the Colony Area plug-in65. 
Host c-Myc quantitation assay 
Parasites used for c-Myc assays were grown for 48 hours with or without 1 
μg/ml ATc and syringe lysed prior to infection of host cell coverslips. Coverslips 
of confluent HFF monolayers were serum starved by pretreating for 24 hours with 
FBS-free medium before being infected. Cells were fixed 19 hours post-infection. 
IFAs for human cMyc, HA, and DAPI were performed as described above. 
Images of phase-contrast, DAPI, HA, MYC, and cMyc channels were acquired 
for at least 20 vacuoles under each experimental condition and exported to 
ImageJ software. Merged-channel images were used to identify infected host cell 
nuclei and then quantitated for cMyc expression from corresponding images of 
the cMyc channel alone. Mean pixel intensity was measured within the host 
nucleus boundaries of singly infected cells containing PVs with greater than one 
parasite. Experiments were done in triplicate and measurements averaged. 
Recombinant expression of GRA44 phosphatase domain 
Recombinant protein expression of the GRA44 phosphatase domain was 
accomplished with the IMPACT expression system utilizing the pTXB1 plasmid 
(New England Biolabs) in Rosetta bacterial cells (Novagen). A section of the 
GRA44 gene encoding amino acids 331 to 693 was amplified from Toxoplasma 
cDNA and cloned into pTXB1 plasmid expression vector with an appended N-




vector by heat shock at 42°C and glycerol stocks made for storage at -80°C. 
Bacterial starter cultures were grown overnight in LB medium with appropriate 
antibiotics at 37°C prior to induction. To induce protein expression, an aliquot of 
fresh cells from a starter culture were grown at 37°C to an OD600 of 0.5 before 
addition of IPTG and 10 µM magnesium sulfate to the media. Induction cultures 
were incubated 18 hours overnight at 30°C and cell pellets obtained by 
centrifugation at 11,000 x g at 4°C for 10 minutes. Proteins were separated and 
visualized by SDS-PAGE and coomassie staining. Recombinant protein solubility 
was assessed by sonicating samples 3 times for 10 seconds in buffer containing 
20mM Tris/HCl, 300mM NaCl, and protease inhibitors (Roche). Lysate was 
centrifuged 20,000xg for 15 minutes at 4°C and supernatant isolated from the 
insoluble pellet.  Both the soluble supernatant and insoluble pellet fractions were 
analyzed by SDS-PAGE and coomassie stain. 
GRA44 phosphatase activity from parasite lysate 
To measure GRA44 phosphatase activity from purified parasite lysates, 
samples were assessed by ELISA methods. 96-well plates were pretreated with 
Rabbit anti HA antibodies at a concentration of 1:1000 overnight at 4°C in sodium 
bicarbonate at pH 9. Plates were washed 5 times with PBS and blocked 1 hour 
with 5% BSA in PBS before introduction of samples. Parasite samples consisted 
of extracellular parasites harvested as described above, but with sonication in 
RIPA buffer containing EDTA-free protease inhibitors (Roche) for 3 times, 10 
seconds each on ice. Goat anti rabbit conjugated to alkaline phosphatase was 




incubated 1 hour at room temperature, washed 5 times with PBS, and incubated 
with para-nitrophenyl phosphate (PNPP) 30 minutes at 37°C. Absorbance was 





Chapter 3: Results 
Bioinformatic identification of secreted phosphatase candidates 
A bioinformatics approach was used for identifying putative secreted 
phosphatases from annotated genes of ToxoDB, a Toxoplasma gondii genome 
database (toxodb.org). The initial BLAST search of all genes within ToxoDB was 
filtered by including only genes whose products contain predicted phosphatase 
domains and signal peptides. This generated a list containing 32 proteins of 
potential interest (Table 1). In order to identify proteins likely to have important 
function in parasite propagation, candidate genes were ranked according to gene 
fitness scores as assigned by a genome-wide CRISPR/Cas9 knockout study67. 
Among the top candidates, TGGT1_228170 contains a predicted acid 
phosphatase domain and, despite having a signal sequence, was previously 
described as being localized to the inner membrane complex (IMC). However, 
further information suggested that the TGGT1_228170 product may indeed be 
secreted. Firstly, the related apicomplexan parasite Plasmodium berghei 
expresses a homologous protein UIS2, which also has a secreted ortholog 
(Pf3D7_1464600) in Plasmodium falciparum. Secondly, TGGT1_228170 has 
been frequently detected in BioID experiments of the PV lumen and PV 
membrane as an interactor of proteins localized to these microenvironments. 
Lastly, closer analysis of the Tg228170 protein sequence reveals multiple 
putative Toxoplasma export elements (TEXEL), originally defined by the 
consensus sequence RXLXD/E although recently refined to the consensus RRL. 




the Golgi as part of the secretory pathway to the PV/PV membrane (PVM) and 
host cell34. Together, this additional information and the fact that TGGT1_228170 
was assigned a gene knockout fitness score of -3.28, indicating an essential 
function to parasite fitness, I decided to revisit the localization and importance of 
this protein. 
 
Table 1. Proteins identified from bioinformatics search. 
The Toxoplasma genome was searched and filtered for genes 
encoding proteins likely to be secreted phosphatases of essential 
cellular function. The search yielded 32 genes in total, which 






Localization of TGGT1_228170 
To characterize the functions of TGGT1_228170, I introduced a DNA 
sequence encoding three C-terminal hemagglutinin (HA) epitope tags (3xHA) 
upstream and adjacent to the stop codon of the endogenous gene locus by 
homologous recombination (Figure 3). Protein extract from both intracellular and 
extracellular parasites of the TGGT1_228170(HA) line showed a band of 
approximately 180 kDa by western blot, which is the expected size for full-length 
protein. However, a second prominent band at approximately 40 kDa was also 
noted in both intracellular and extracellular parasite samples (Figure 3B). This 
smaller band is consistent with processing at either of two sequences with 
homology to TEXEL sites. The sequence for the first of these putative cleavage 
sites is RELEE (amino acids 1205 to1209), consistent with the former TEXEL 
consensus, while the second sequence is RRLLE (amino acids 1348 to 1352), 
consistent with the updated RRL consensus (Figure 3A). 
 
Figure 3. TGGT1_228170 is processed into at least two forms. 
Schematic for HA epitope tagged 228170 gene (A) showing 
locations of signal peptide (SP), phosphatase domain, putative 
TEXEL sequences, and 3x HA epitopes (HA). Lysate 




showed long and short bands by western analysis (B). MS 
analysis of long and short bands identified the short band as 
predominantly C-terminal peptides (C). 
 
Samples were further analyzed by mass spectrometry (MS) to confirm the 
identity of the smaller protein band. To accomplish this, endogenously tagged 
TGGT1_228170 protein was immunoprecipitated and the eluate separated by 
SDS-PAGE. Both the 180-kDa (long) and 40-kDa (short) bands were excised 
from the PAGE gel and analyzed as separate samples (Figure 3C). Results 
confirmed that both bands corresponded to TGGT1_228170. A total of 192 
peptides were detected for the long band with a mapped distribution covering the 
full protein sequence. MS analysis of the short band revealed a total of 74 
peptides corresponding to TGGT1_228170 with 60 of these mapping specifically 
to regions after the second putative TEXEL sequence (Figure 3C). Therefore, 
TGGT1_228170 is processed and both the full-length protein and C-terminal 
fragment are stable. 
To determine protein localization, immunofluorescence assays (IFAs) 
were performed of intracellular TGGT1_228170(HA) parasites (Figure 4). 
Consistent with the presence of a signal sequence and putative TEXEL sites, 
TGGT1_228170 was detected within the PV lumen and at the PV membrane 
(PVM) in particular (Figure 4, arrows). Based on this localization and 
corroborative findings by Coffey et al27. for the same protein, TGGT1_228170 





Figure 4. GRA44 is secreted into the parasitohporous vacuole. 
Immunofluorescence assay (IFA) of intracellular parasites 
expressing TGGT1_228170(HA) stained for HA in yellow. 
Endogenously tagged GRA44 localizes to PV lumen and PV 
membrane. PV membrane localization was observed to be dynamic 
and at highest intensity (arrows). Scale bars are 2 µm. 
 
TGGT1_228170 is cleaved at TEXEL site 
The small C-terminal fragment of GRA44 detected by western blotting and 
MS is the product of cleavage at either of two putative TEXEL sequences which 
are located approximately 100 residues apart. To investigate which of the two 
sites is cleaved if not both, GRA44(HA) mutant variants were exogenously 
expressed with the first arginine of either TEXEL site or both sites switched to 
alanine (Figure 5A). Mutating the first arginine of TEXEL sites to alanine has 
previously been shown to reduce cleavage. Mutation of the first putative site 




blot. However mutation of the second site (GRA44 R1348A) significantly reduced 
processing and short band density (Figure 5B). The same result was observed 
when both putative TEXEL sites were mutated (GRA44 R1205A/R1348A). 
Densitometry analysis showed that the wild-type version of the protein was 
effectively cleaved (82.9%±9.9%, n=3), and processing of GRA44 R1348A was 
reduced, (47.4%±9.9%, n=3). Thus, it appears that the second TEXEL of GRA44 
is processed, and will be referred to as the GRA44 TEXEL. Although a significant 
reduction in cleavage was observed after altering these single amino acids in the 
GRA44 TEXEL, there appeared to be some residual C-terminal cleavage product 
present in all cases. To ascertain whether this was the effect of persistent 
cleavage, despite the mutations, or cleavage at an alternative site, I generated 
an exogenously expressed GRA44 mutant in which all 5 amino acids that make 
up this TEXEL (amino acids 1348 to 1352) were deleted from the protein 
sequence (GRA44 Δ1348–1352). As expected, TEXEL deletion resulted in a 
significant loss of the C-terminal cleavage product (Figure 5C). However, it was 
evident that there still remained a measurable amount being cleaved. The 
cleavage level for theΔ1348–1352 mutant was calculated to be 21.1%±7.7% 





Figure 5. TEXEL 2 of GRA44 is predominantly cleaved. 
To determine the site responsible for the processing of GRA44, 
exogenous copies of mutated GRA44(HA) were expressed in 
parasites where the first arginine of each putative cleavage site was 
mutated to alanine individually (R1205A and R1348A) or 
simultaneously (R1205A/R1348A) An additional mutant of 
GRA44(HA) was expressed in which the 5 amino acids of the 
second putative TEXEL site were deleted (Δ1348–1352). (A) 
Diagram of the TEXEL consensus sequence and putative sites in 
GRA44, with mutated amino acids indicated in red. (B) Western blot 
of lysates from parasites expressing the exogenous GRA44(HA), 
the R1205A or R1348A mutant version, or the double 
R1205A/R1348A mutant probed for HA. (B) (Left) Western blot of 




lacking the second site (the Δ1348–1352 mutant) probed with 
antibodies against the HA epitope tag.(Right) Percent cleavage in 
the wild-type, R1205A, and Δ1348–1352 strains, determined by 
calculating the ratio of the density of the large band (L) over the 
sum of the density of both bands (SL).The results for all data sets 
(n=3, mean ± SD) were significantly different from those for the 
others, based on one-way analysis of variance (P˂0.05). (D) 
Representative images of intracellular parasites expressing each of 
the four GRA44 processing mutants. Images are of the 
immunofluorescence signal from the HA tag (in yellow) and of the 
HA signal overlaid on the phase image. Bars=2 μm. 
 
For a thorough examination of the identified TEXEL, I generated parasites 
exogenously expressing GRA44 in which either L1350 or E1352 was mutated to 
alanine. As was the case for the R1348A mutation, changing the central leucine 
to an alanine disrupted cleavage processing (Figure 6); however, mutant E1352A 
showed levels of processing similar to wild-type (Figure 6). Since TEXEL 
cleavage persisted despite all mutations and outright sequence deletion, it is 
plausible that a cryptic site, potentially amino acids 1205 to 1209, was being 
cleaved instead. Alternatively, GRA44 may be cleaved by a TEXEL/ASP5-
independent mechanism. IFAs were performed of parasite lines expressing each 
of the four mutant GRA44 proteins (R1205A, R1348A, R1205A/R1348A, and 
Δ1348–1352 mutants) to determine whether effective processing is needed for 
correct localization to the PV. Interestingly, none of the mutations affected 
secretion or localization to the PV (Figure 5D). Similarly, mutating L1350 or 
E1352 within the confirmed TEXEL site had no affect on PV localization of 
GRA44 (Figure 6C). Based on these results, complete processing at the TEXEL 





Figure 6. Further TEXEL mutations showed no effect on secretion. 
Exogenous copies of GRA44(HA) in which each of three conserved 
residues of the RxLxD/E motif were individually mutated in the 
primary TEXEL were expressed in parasites to assess effects on 
cleavage efficiency and secretion. (A) Diagram of primary TEXEL 
showing WT amino acid sequence and mutated sequences with 
specific residues mutated to alanine indicated in red. (B) Western 
blot of parasite lysates showed mutation of leucine to alanine 
(L1350A) resulted in cleavage reduction, while mutation of 
glutamate (E1352A) had no observable effects. (C) IFA of 
intracellular parasites exogenously expressing mutant GRA44(HA) 
constructs reveal these mutations also had no observable adverse 
effects to GRA44 secretion. 
 
Cleavage products colocalize in PV 
Initially, the GRA44(HA) parasite lines used for study were constructed 




at an internal TEXEL site, only full-length uncleaved protein and the post-
cleavage smaller C-terminal fragment could be detected by western blot and IFA. 
As a result, localization of the N-terminal cleavage product, which contains the 
putative acid phosphatase domain, could not be determined with these parasite 
lines. Accordingly, I engineered a parasite line to exogenously express GRA44 
with an internal MYC epitope tag inserted between amino acids 1203 and 1204, 
along with a C-terminal HA epitope tag (Figure 7A). Protein extracts from 
parasites expressing the dually tagged GRA44 were analyzed by Western blot 
and probed separately with antibodies against the MYC or HA epitopes (Figure 
7B). Probing of anti-MYC uncovered an additional band at approximately 140 
kDa, which correlates to the expected N-terminal end of GRA44 post-cleavage. 
Probing of anti-HA showed full-length GRA44 and the C-terminal fragment similar 
to previous experiments. After establishing this parasite line to allow for 
monitoring of both N-terminal and C-terminal post-processing fragments of 
GRA44, I investigated their respective localizations by IFA (Figure 7C). 
Regardless of whether HA or MYC antibodies were used, the protein was 
localized primarily to the PV, which suggests that the two major polypeptides, 





Figure 7. N-terminal cleavage product of GRA44 is secreted. 
(A) To determine size and localization of the GRA44 N-terminal 
cleavage product, an exogenous copy of GRA44 with an internal 
MYC epitope tag and a C-terminal HA epitope tag was expressed 
in parasites. (A) Schematic of the exogenous GRA44 construct 
MYC-TXL-HA illustrating positions of the MYC and HA epitope tags 
relative to the both putative TEXEL motifs. (B) Western blot of the 
MYC-TXL-HA parasite line separately probed with anti-HA and anti-
MYC antibodies showed a total of three bands for GRA44. (C) IFA 
images of parasites expressing MYC-TXL-HA probed for HA 
(yellow) and MYC (magenta). Bar=2 μm. 
 
Knockdown compromises parasite growth 
A genome-wide CRISPR screen had previously assigned GRA44 a log2 
relative fitness score of -3.28, which would suggest that loss of the protein would 
be significantly detrimental to parasite propagation. Due to this predicted 
importance to fitness and survival, I applied a tetracycline (Tet)-repressible 
system to establish a conditionally controlled GRA44 knockdown line. More 




transactivator (TATi) protein and tetracycline response element (TRE) just 
upstream of the endogenous GRA44 start codon (Figure 8A). The conditional 
knockdown line was engineered using the endogenously tagged GRA44(HA) 
parasites for straightforward monitoring of GRA44 protein expression. The 
resulting parasite line,TATi-GRA44(HA), was grown for 24 or 48 hours in the 
absence and presence of the tetracycline analog anhydrotetracycline (ATc), and 
GRA44 expression monitored by Western blotting and IFA. At both time points, 
protein levels were significantly reduced in the presence of ATc (Figure 8B and 
C). Thus, the conditional knockdown feature functioned properly in the parasite 
line. Interestingly, the small C-terminal fragment from the TATi-GRA44(HA) 
parasites was smaller than what was observed with the parental endogenous 
HA-tagged strain. Sequencing of GRA44 in the TATi-GRA44(HA) line showed 
that a 315-bp fragment, encoding the last 105 amino acids, was deleted, but with 
the HA tag in frame. Surprisingly, no significant propagation defects were 
detectable and this line was successfully complemented with a full-length gene 
construct (compare the results of the parental parasites to those of the 
knockdown grown without ATc). Thus, deletion of the region does not affect 
localization or function. Regardless, this strain allowed for studying effects of 
eliminating GRA44 expression with ATc addition. Importantly, when grown in the 
presence of ATc, depleting GRA44, propagation of TATi-GRA44(HA) parasites 
was significantly affected as compared to their propagation under normal 
conditions (Figure 8D). For the conditional knockdown strain grown in absence of 




reduced to 0.9%±0.4% on addition of ATc to the growth medium. So, conditional 
knockdown of GRA44 significantly reduces parasite propagation in tissue culture. 
To confirm that the propagation defect was due to reduction of GRA44 
levels, TATi-GRA44(HA) parasites containing an exogenous copy of GRA44 
were developed to complement the phenotype. A copy of GRA44 with a C-
terminal MYC epitope tag driven under tubulin was introduced to the TATi-
GRA44(HA) line at the endogenous Ku80 locus to generate the complement line, 
TATi-GRA44(HA)comp, (Figure 9A). The exogenous copy of GRA44(MYC) was 
processed and secreted as expected (Figure 9B and C). Without ATc, both the 
endogenous HA-tagged GRA44 and the exogenous MYC-tagged GRA44 were 
detected in this line by Western blotting and IFA (Figure 9B and C). As expected, 
addition of ATc resulted in knockdown of GRA44(HA) but had no effect on 
exogenous GRA44(MYC) expression. Plaque assays of TATi-GRA44(HA) and 
TATi-GRA44(HA)comp parasites were performed in parallel with and without ATc 
to determine if the GRA44 extra copy complemented the propagation defect. 
Consistent with previous results, addition of ATc to TATi-GRA44(HA) severely 
impaired growth, however TATi-GRA44(HA)comp parasites were relatively 
unaffected by presence of ATc (Figure 9D). The percent clearance of host cell 
monolayer after 5 days in culture with ATc was 0.8%±0.4% for the knockdown 
strain and 26.6%±3.7% for the complemented strain, statistically equal to 
clearance observed without ATc by either parasite line. Complementation of the 
plaque formation phenotype by addition of a wild-type copy confirms that GRA44 





Figure 8. Conditional knockdown of GRA44 stalled parasite growth. 
To determine the function of GRA44, a tetracycline (Tet)-
repressible system was applied to establish a conditional GRA44 
knockdown parasite line. (A) Schematic of GRA44 conditional 
knockdown strategy (B) Quantitative Western blot of TATi-
GRA44(HA) parasites grown for either 24 or 48 hours in the 
absence or presence of ATc. Blots were probed with HA antibodies 
to detect GRA44 with SAG1 used as a loading control. (C) The 
reduction in GRA44 expression in the presence of ATc was 
confirmed by IFA of intracellular TATi-GRA44(HA) parasites grown 
with and without ATc for 24 or 48 hours and probed with anti-HA 
antibodies. Bars=2 μm. (D) Plaque assays were performed with 
GRA44(HA) parasites (parental) or TATi-GRA44(HA) parasites 
grown with or without ATc for 5 days. (Left) Representative plaque 
assay images. (Right) Results were quantified based on the 
percentage of cell monolayer cleared by parasite propagation 
(cleared area) and the average for biological and experimental 
triplicates (n=3; mean ± SD; P˂0.0001, unpaired t test). 
 
Cleavage and function 
The GRA44 protein has an essential function in parasite propagation and 




determine if the processing of this TEXEL is needed for function, the TATi-
GRA44(HA) strain was complemented with an exogenous copy of GRA44(MYC) 
containing a deletion of TEXEL residues 1348 to 1352, giving the 
GRA44compΔTXL parasite line. For GRA44compΔTXL parasites under normal 
growth conditions, anti-HA probing detected endogenous GRA44(HA) by western 
blotting, similar to that in the TATi-GRA44 and TATi-GRA44comp lines. Probing 
blots with anti-MYC antibodies detected the exogenous MYC-tagged 
GRA44compΔTXL copy as mostly full-length protein, unlike the TATi-
GRA44comp, which was processed (Figure 9E). Under knockdown conditions 
with ATc, the GRA44compΔTXL complemented parasite line remained 
unaffected (Figure 9F) and exhibited relatively normal host cell clearance. These 






Figure 9. GRA44 knockdown complemented by rescue with WT 
GRA44. 
To determine that the lack of GRA44 elicits the observed 
phenotype, a complemented line was established by adding an 
exogenous copy of wild-type GRA44 to the TATi-GRA44(HA) 
conditional knockdown line. (A) Schematic of strategy used for 
complementation. The wild-type copy of GRA44 added to the TATi-
GRA44(HA) line contains a C-terminal MYC epitope tag and is 
driven by the Toxoplasma tubulin gene promoter (tub) in the TATi-
GRA44(HA)comp parasite line. (B) Western blot of lysates from 




hours. Blots were probed for HA and MYC. (C) Representative IFA 
images of TATi-GRA44(HA)comp with and without ATc treatment 
stained for the HA-tagged regulatable GRA44 and the MYC-tagged 
constitutively expressed exogenous copy. Bars=2 μm. (D) (Left) 
Plaque assays were performed with knockdown TATi-GRA44(HA) 
and the complemented TATi-GRA44(HA)comp parasites grown 
with or without ATc for 5 days. (Right) The average percentage of 
cleared cell monolayer from biological and experimental triplicates 
is shown on a bar graph (n=3; mean ± SD; ****, P˂0.0001; n.s., not 
significant [significance was determined by one-way analysis of 
variance, followed by Tukey’s test]). (E) TATi-GRA44(HA) was 
complemented with an exogenous copy of GRA44 containing a 
TEXEL deletion of amino acids 1348 to 1352 with a C-terminal 
MYC tag to give TATi-GRA44(HA)compΔTXL parasite line. Lysates 
from TATi-GRA44(HA), wild-type complemented strain TATi-
GRA44(HA)comp, and ΔTXL complemented strain TATi-
GRA44(HA)compΔTXL were analyzed by western blot and probed 
for HA and MYC. (F) Plaque assays were performed with the TATi-
GRA44(HA) andTATi-GRA44(HA)compΔTXL lines. Parasites were 
grown 5 days with or without ATc. The average percentage of cell 
monolayer cleared for biological and experimental triplicates is 
shown on a bar graph (n=3; mean ± SD; ****, P˂0.0001; n.s., not 
significant [significance was determined by one-way analysis of 
variance, followed by Tukey’s test]). 
 
Interaction with translocation machinery 
Results presented thus far have shown GRA44 to be of significant 
importance for successful parasite propagation, but details about this protein's 
function and  how it is important remain unclear. To better understand the context 
for GRA44 function, a comprehensive interactome of significant GRA44 protein 
interactors was established (Table 2). In short, GRA44 protein was isolated from 
GRA44(HA) parasite lysates by immunoprecipitation and peptides of co-
precipitating proteins were analyzed by mass spectrometry. Experiments were 
done in triplicate for both anti-HA and nonspecific controls, and data statistically 




analysis. With a SAINT score of ˃0.8 used as a cutoff, a list of 35 putative 
interactors was generated. Of 35 interactors, 8 were ribosomal and snRNP 
proteins, which are likely of no importance to GRA44 function. Of the remaining 
27 putative interactors, 23 had predicted signal peptides, indicating they are 
potentially secreted proteins. Among these were 8 known GRA proteins (GRA9, -
16, -25, -33, -34, -45, -50,and -52); the PV membrane-associated protein MAF1; 
and MYR1, a member of the effector translocation system. 
 
Table 2. GRA44 interactome. 
Top protein interactors of GRA44 in order of interaction significance 
as determined by SAINT. 
 
To confirm the interaction with MYR1, for which there are antibodies, 
coimmunoprecipitation (co-IP) assays were performed (Figure 10). Purified lysate 




controls done similarly with nonspecific mouse IgG beads. Eluates were 
evaluated by western blotting for presence of both GRA44 (Figure 10A) and 
MYR1 (Figure 10B and C). For MYR1, which is also processed by ASP5 at an 
internal TEXEL site, samples were probed with antibodies for either C-terminal or 
N-terminal cleavage products. Western analysis of eluate from GRA44 
immunoprecipitation yielded significant amounts of both MYR1 segments 
compared to that in control eluate from the same source. This data would 
suggest that GRA44 interacts with MYR1, a protein with known importance to 
effector translocation. 
 
Figure 10. MYR1 immunoprecipitates with GRA44. 
Beads conjugated to HA antibodies were used to IP GRA44(HA) 
with mouse IgG beads used as a nonspecific control. Eluate 
sample probed for HA by Western blot showed successful IP of 
GRA44 (A). Probing for MYR1 yielded bands for both N-terminal 
(B) and C-terminal (C) domains in the GRA44 eluate. 
 
Host cMyc induction 
Identification of MYR1 as a protein important to effector translocation was 
accomplished by a forward genetic screen of parasite mutants exhibiting 
translocation defects and consequential loss of host nuclear cMyc upregulation. 




factor cMyc by translocation of GRA16 and GRA24 to the infected host cell's 
nucleus. Given GRA44’s interaction with MYR1, it was plausible that it may be 
involved in similar functions related to translocation. To determine if this was 
indeed the case, TATi-GRA44(HA) parasites were assessed for their ability to 
induce host nuclear cMyc upregulation under knockdown conditions (Figure 11). 
To do this, parasites were first grown 24 hours with ATc, released from the host 
cells, and allowed to infect new cells under constant ATc conditions. After 12 
hours of growth in the new host cells, cultures were fixed and an IFA for human 
cMyc was performed (Figure 11A). Control cultures were grown and treated 
identically with the exception of ATc, which was omitted from all steps. Images 
obtained by merged phase-contrast microscopy and HA, MYC, DAPI (4,6-
diamidino-2-phenylindole), and cMyc staining were used to locate infected host 
cells with only those cells infected by single PVs with greater than 1 parasite per 
vacuole used for analysis. Single-channel images of cMyc staining within these 
host nuclei boundaries were quantitated with ImageJ software (Figure 11B). 
Addition of ATc to TATi-GRA44(HA) parasites significantly reduced GRA44 
levels and reduced the cMyc signal by approximately 5-fold, a significantly 
subdued response compared to the control assay. No significant differences in 
the induced cMyc signal were observed in the complemented strain under ATc 
knockdown conditions. The GRA44 complement has also been successfully used 
to rescue GRA16 host-nuclear transolocation inhibition, as observed by IFA, 





Figure 11. Host cMyc induction is dependent on GRA44. 
Host nuclear cMyc expression was quantified by fluorescence 
microscopy after invasion by either the knockdown TATi-
GRA44(HA) or the complemented knockdown TATi-
GRA44(HA)comp parasite lines in the presence and the absence of 
ATc. (A) Representative IFA images of TATI-GRA44(HA) parasites 
grown without (- ATc) or with (+ ATc). Cultures were stained for HA 
to detect GRA44 (yellow), DAPI to detect nuclei (blue),and host 
cMyc (magenta). Arrows point at PVs containing more than 2 
parasites. (B) Graph represents the average quantified nuclear 
signal from cMyc antibody staining across biological and 
experimental triplicates. Arbitrary units (AU) were used in 
comparing the nuclear cMyc signal intensity (n = 3; ****, P˂0.0001; 
n.s., not significant [significance was determined by one-way 
analysis of variance, followed by Tukey’s test]). 
 
Measuring GRA44 phosphatase activity 
The putative phosphatase domain of GRA44 was recombinantly 




and internal intein domain. The CBD tag facilitates protein purification by affinity 
column with a chitin resin and allows for quick elution via reduction-dependent 
intein cleavage. The presumed sequence of the GRA44 phosphatase domain 
was fused to the CBD tag and expressed in Rosetta cells (Figure 12). Two 
concentrations of IPTG were assessed for effectiveness, although none of the 
recombinant protein appeared soluble upon western blot analysis (Figure 12B). 
No significant difference in amounts or solubility of protein was observed using 
either 0.4 mM or 1.0 mM IPTG for induction. 
 
Figure 12. Recombinant GRA44 domain was expressed in E. coli. 
(A) Schematic of GRA44 expression construct containing putative 
phosphatase domain (amino acids 331 to 693) fused to intein-CBD 
tag.(B) Induction samples were separated by centrifugation to 
isolate soluble protein and analyzed by Western blot. 
 
Due to difficulties in expressing recombinant GRA44 protein for the 




pursued. For this alternative approach, GRA44 was assayed from GRA44(HA) 
parasite lysate by a modified ELISA method (Figure 13). Rabbit anti-HA 
antibodies were affixed to a 96 well plate, blocked with nonspecific BSA protein, 
and incubated with parasite lysate. This was followed by washing and incubation 
with para-nitrophenyl phosphate (PNPP) substrate. The method was first tested 
with a commercial goat anti rabbit alkaline phosphatase antibody conjugateas a 
positive control. The goat anti rabbit antibody was successful in binding the rabbit 
anti HA antibodies of the ELISA plate and produced a significant amount of 
cleaved pNPP substrate at pH 8, as measured by absorbance at 405 nm (Figure 
13A). ELISA plates were incubated with purified GRA44(HA) parasite lysate at 
different pH values (Figure 13B). Purified lysate from untagged parental parasites 
was included as a negative control in addition to alkaline phosphatase (AP) 
antibody conjugate for a positive control. Absorbance measurements yielded no 
significant differences between GRA44(HA) and parental samples, suggesting a 
lack of any enriched phosphatase activity in those samples. The positive control 





Figure 13. Phosphatase activity of parasite lysate. 
(A) Positive control goat anti rabbit alkaline phosphatase conjugate showed 
increasing phosphatase activity with increasing enzyme concentration at pH = 8 
(N=1). (B) Parental and GRA44(HA) lysates showed no activity at different pH, 
while the alkaline phosphatase positive control showed significant cleavage of 
pNPP substrate (N=1). 
 
Full experimental datasets and uncropped figures are available as 




Chapter 4: Discussion 
The presented data strongly suggest GRA44 to be a PV-resident protein 
with an essential cellular function likely correlated to Toxoplasma's global 
secretory pathway. The secretory pathway is required for translocation of 
parasite effector proteins to the host cell where they induce status changes to 
host processes. Parasite-driven host changes largely follow a general trend of 
increased metabolism and growth, with dysfunctional innate immune and 
apoptotic pathways. Conceptually, sustaining host cell growth pathways and 
elevated metabolism is analogous to an induced state of cellular overdrive, which 
helps provide an intracellular environment richer in essential biological molecules 
such as nulceotides, metabolic intermediates and simple lipids. Simultaneously 
suppressing host innate immune function and apoptosis allows Toxoplasma to 
replicate unhindered, while within an artificially enriched environment. An 
essential component of the translocation system is the MYR1/2/3 complex, 
however mechanistic details remain unknown. MYR1 and MYR3 are known to 
directly associate through presumed protein interactions, while MYR2 likely is a 
more transient interacting member32. Many of Toxoplasma's secreted proteins 
are highly disordered in nature, so an active transport system would be probable, 
although this is largely speculation.  
Knockdown of GRA44 resulted in significant reduction of host cMyc 
activation, a similar phenomenon observed in MYR1 knockout parasites. This 
result combined with strong evidence of direct association with MYR1 supports 




system and that GRA44 interaction with MYR1 is functionally relevant. Additional 
work by Cygan et al. further corroborates the idea of GRA44 being essential to 
parasite secretion by showing that GRA44 knockout parasites are unable to 
secrete the effector GRA16 to the host, a defect rescued by transient expression 
of wild-type GRA44. Whether GRA44 functions as a structural or regulatory 
protein remains unknown and requires further investigation. The possibility that 
GRA44 acts in a regulatory capacity is supported by the presence of a putative 
catalytic site reminiscent of acid phosphatases. In addition to multiple classes of  
phosphatases, Toxoplasma also expresses pseudophosphatases, catalytically 
inactive enzymes theorized to function through binding of certain key targets 
within cellular pathways. This compares to pseuodokinases, which have been 
observed to be secreted as a means to affect host systems. Whether GRA44 is 
an active phosphatase or a pseudophosphatase is unknown, but either type has 
potential to impact parasite propagation. In the biology of animals, plants, and 
fungi, acid phosphatases similar to GRA44 serve many biological purposes, and 
proteins are characterized by a shared catalytic site structural arrangement 
(Figure 14)46,69. These enzymes coordinate two metals in the active site, usually 
an Fe(III) and another metal such as Mn(II), Zn(II), or Fe(II). Each metal is 
separately coordinated to 3 amino acids with a shared aspartic acid bridge 
between them. The Fe(III) atom is typically coordinated to a histidine, aspartate, 
and tyrosine with the divalent metal atom coordinated by two histidines and an 





Figure 14. Active site of acid phosphatase. 
The active site of red kidney bean purple acid phosphatase is represented  to 
illustrate the coordination of metal atoms with seven key amino acids. 
 
From phosphatase domain homology alignments, GRA44 appears to 
contain a majority of the conserved residues common to acid phosphatases, but 
the aspartate conjugating the Fe(III) is replaced by an asparagine and the 
asparagine conjugating the second metal is replaced by a glutamate (Figure 
15)69. This would represent a swap in charged amino acids, but still maintains a 
stable charge equilibrium within the active site. The only coordinating residue 
unaccounted for is the tyrosine binding Fe(III). The active site of GRA44 is then 
hypothesized to consist of the first metal, M(II), coordinated by glutamate and two 
histidines, and the second metal, M(III), bound by an asparagine, histidine, and 





Figure 15. GRA44 has residues common to acid phosphatases. 
In the GRA44 phosphatase domain (GRA44 PD), there is an 
apparent swap of the N and E amino acids between metal 
coordinating sites. Residues coordinating the first metal are marked 
(#) and second metal (*). The shared aspartate bridge is annotated 
by (=). 
 
The cellular roles of acid phosphatases vary greatly, but are usually 
centered around scavenging, recycling, and transport of inorganic phosphorus. In 
humans, acid phosphatases have been ascribed function in cell signaling, such 
as downregulation of prostate cell growth and osteoclast bone resorption 
activity45,46. In plants, acid phosphatases have been implicated in phosphate 
acquisition from organophosphate compounds and protein dephosphorylation of 




with the MYR translocon in the PV, where it could regulate MYR proteins by 
protein dephosphorylation activity. The MYR3 protein has been observed in a 
phosphorylated form, indicating a dynamic phosphorylative status31. ROP17, a 
secreted kinase, has been shown critical for efficient effector translocation, which 
is consistent with the idea of phosphoregulation of the translocation system70. 
GRA44 could plausibly have a role in this hypothetical phosphoregulation, either 
through MYR3 or other proteins. Alternatively, GRA44 could be important for 
dephosphorylating effectors prior to trafficking across the PVM barrier. For 
transport across a lipid bilayer membrane, such as the PVM, proteins may 
require dephosphorylation. Notably, both GRA16 and GRA24 have been shown 
to exist primarily as phosphorylated proteins, as identified by a phosphoproteome 
analysis in Toxoplasma71. 
Although GRA44 knockdown results in defective host cMyc activation and 
a significant propagation defect, disruption of other translocon members does not 
adversely affect propagation to a similar degree. The relative fitness scores 
assigned to these genes by Sidik et al reflect this difference, where the score for 
GRA44 is -3.28 the relative fitness scores for MYR1, MYR2, and MYR3 are 0.88, 
2.39, and 2.83, respectively67. This discrepancy is peculiar because disruption of 
MYR1, MYR2 or MYR3 interferes with effector translocation and cMyc activation. 
Additionally, the MYR1-dependent effectors GRA16, GRA24, and TgIST also 
have positive knockout fitness scores of 1.44, 2.28, and 2.86, respectively. 
Consequently, it must be concluded that the propagation defect exhibited by 




An alternative explanation to GRA44's importance regarding propagation and its 
link to translocation is that GRA44 has multiple independent roles, one of which 
is nutrient acquisition like many other common smaller-sized acid 
phosphatases72. A multipurpose functionality would be consistent with the 





Chapter 5: Conclusion and future directions 
Conclusions 
During its life cycle, Toxoplasma invades and replicates within host cells, 
where nutrient resources are readily available and consistently produced. To 
better facilitate their life cycle, Toxoplasma employs many means of altering the 
status of their host to better suit their needs. Examples of parasite-driven host 
alteration include apoptosis inhibition, innate immune system disruption, host 
cytoskeleton restructuring, and global changes to host gene 
transcription26,28,32,73–75. Host cell alterations such as these are accomplished by 
a specialized arsenal of parasite effector proteins secreted into the host cell 
during all stages of parasite development. Most of these effectors are secreted 
by one of two unique parasite organelles: the rhoptries and the dense granules. 
Rhoptries discharge the majority of proteins known as ROPs and RONs during 
invasion, but some ROPs are secreted during parasite replication. Dense 
granules release their contents into the PV after invasion, during intracellular 
division and parasite growth. While some of these secreted proteins remain 
within the PV lumen or associate with the PVM, many are translocated across 
the PVM into the host, where they affect numerous host functions. The 
mechanism of protein secretion from PV to host has become clearer with the 
discovery of associated proteins appearing to comprise components of a 
translocation system30,31. My work on the protein GRA44 (TGGT1_228170), 
previously named as IMC2A54, has identified it as an additional interacting 




downstream of effector translocation. This study showed GRA44 to be necessary 
for host cMyc activation, one of many alterations imposed on the host by 
Toxoplasma. GRA44 was also found to be essential for parasite propagation, a 
characteristic not seen in the other translocon system members. In addition, this 
study showed GRA44 to be cleaved at an internal TEXEL site located at residues 
1348 to 1350 and secreted into the PV. Interruption of cleavage at this site had 
no inhibitory effects to GRA44 secretion or parasite propagation. Interestingly, 
both major GRA44 cleavage products were observed to be secreted into the PV 
where they largely colocalized. This is important, as the fragment containing the 
putative acid phosphatase is part of the N-terminal cleavage product, which was 
seen localizing in the PV lumen and PVM. The fact that TEXEL processing was 
not necessary for either the secretion or function of GRA44 is consistent with 
reports of other secreted proteins containing TEXEL motifs, such as MYR1 and 
WNG1/2, which can still be secreted even in the absence of ASP5 protease 
activity27.  By chance, the GRA44 knockdown line presented with a spontaneous 
gene deletion likely occurring from a local DNA recombination event, however 
this would prove an unexpectedly fruitful situation since it made clear that the last 
105 amino acids of the protein are not needed for function or localization. This 
finding suggests the C-terminus of GRA44 may not confer any function, a 
concept in line with the fact that C-terminal TEXEL cleavage has no effects to 
protein functionality. Analysis of proteins co-immunoprecipitating with GRA44 
revealed interactions with many known secreted proteins, including numerous 




network; GRA16, an effector altering the host cell cycle through the p53 pathway; 
GRA25, a macrophage dependent immune modulator, and members of the 
multicopy mitochondrion association factor 1 (MAF1) family of proteins essential 
for recruiting host mitochondria to the PVM surface29,76–78.  The proteins GRA33, 
GRA34, GRA45, GRA50, GRA52 which have yet to be functionally characterized 
were also found to interact with GRA44. Most importantly, immunoprecipitation 
revealed an interaction between MYR1 and GRA44, which was independently 
confirmed by western blotting (Figure 10). While studying the interactome of 
GRA44, I learned of ongoing work in John C. Boothroyd’s lab showing a physical 
and functional interaction between MYR1 and GRA4468. MYR1 was initially 
identified through a forward genetic screen for Toxoplasma mutants unable to 
activate host c-Myc and translocate the effectors GRA16 and GRA2430. Further 
screening for such mutants identified MYR2 and MYR331. Together MYR1/2/3 
appear to be part of a putative translocon complex, although only MYR1 and 
MYR3 have been confirmed to directly interact by western blot. MYR1-dependent 
effectors are responsible for driving a broad range of host cell alterations 
including the upregulation of E2F transcription factors and the downregulation of 
interferon signaling32. 
In conclusion, I have shown GRA44 to be a secreted protein, critical for 
Toxoplasma propagation and host manipulation, that is an additional member to 
the MYR1/2/3 tranclocation complex through direct protein interactions with the 
translocon protein MYR1. Prior to secretion, GRA44 is cleaved at an internal 




by which GRA44 functions in regards to protein secretion to host cells remains 
unknown, however, due to its putative acid phosphatase domain, involvement 
with the dephosphorylation of trafficked proteins or members of the translocon 
complex is a plausible explanation. 
Future directions 
Further study of GRA44 and its role in parasite propagation will 
necessitate characterization of any enzymatic properties of the protein. 
Expression of the phosphatase domain in a eukaryotic system such as insect 
cells or yeast could expedite this inquiry, although the fact that GRA44 is a metal-
dependent protein specific to Toxoplasma likely requiring specific chaperonins for 
correct conformational folding remains an obstacle. For future work, 
complementation of GRA44 knockdown parasites with exogenous GRA44 
containing point mutations of key active site residues would allow for study of 
certain amino acids and their importance to function. Additionally, further 
development of the parasite lysate ELISA method for phosphatase activity 
measurements could yield more detailed enzymatic information of GRA44. In this 
work, all experiments have been conducted in Type I Toxoplasma, a strain 
unable to assume the bradyzoite stage and efficiently form cysts. Type II 
parasites are able to fully change stages between tachyzoite and bradyzoite, and 
therefore express a multitude of bradyzoite-specific proteins. Study of GRA44 in 
type II parasites may uncover more specific phenotypic results, since this 
parasite strain exhibits a more dynamic transcriptional profile involving gene sets 




GRA44, potential substrates, and phenotypic data from other parasite stages will 
aid in uncovering more information on the regulation of effector translocation in 
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